Table of Contents
Table 5-55: Morgan
Table 5-57: Noble
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 34 | 488.0 | 177 | 523.8 | 17 | 265.6** | 92 | 289.4 |
| Esophagus | * | # | 3 | # | * | # | 4 | # |
| Stomach | * | # | 2 | # | * | # | 1 | # |
| Colon excluding Rectum | 5 | 71.1** | 14 | 45.2** | * | # | 10 | 32.6** |
| Rectum and Rectosigmoid Junction | * | # | 5 | 13.5** | * | # | 2 | # |
| Liver | * | # | 1 | # | * | # | 1 | # |
| Pancreas | * | # | 5 | 19.6** | * | # | 6 | 22.6** |
| Lung and Bronchus | * | # | 38 | 114.4 | 7 | 105.0** | 36 | 110.3 |
| Melanoma of the Skin | * | # | 4 | # | * | # | 0 | # |
| Prostate | 13 | 197.6** | 54 | 158.0 | * | # | 4 | # |
| Urinary Bladder | * | # | 5 | 14.4** | * | # | 1 | # |
| Kidney and Renal Pelvis | * | # | 6 | 16.3** | * | # | 2 | # |
| Brain and Other Nervous System | * | # | 3 | # | * | # | 2 | # |
| Non-Hodgkin Lymphoma | * | # | 7 | 19.7** | * | # | 3 | # |
| Myeloma | * | # | 0 | # | * | # | 1 | # |
| Leukemia | * | # | 2 | # | * | # | 4 | # |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 42 | 517.4 | 158 | 394.7 | 13 | 159.0** | 63 | 149.9 |
| Colon excluding Rectum | * | # | 15 | 34.2** | * | # | 8 | 17.7** |
| Rectum and Rectosigmoid Junction | * | # | 8 | 19.2** | * | # | 0 | # |
| Liver | * | # | 0 | # | * | # | 0 | # |
| Pancreas | * | # | 2 | # | * | # | 3 | # |
| Lung and Bronchus | 9 | 105.0** | 19 | 46.9** | * | # | 13 | 30.2** |
| Melanoma of the Skin | * | # | 2 | # | * | # | 0 | # |
| Breast | 7 | 86.2** | 50 | 125.2 | * | # | 6 | 14.1** |
| Cervix Uteri | * | # | 5 | 13.7** | * | # | 1 | # |
| Corpus Uteri | * | # | 8 | 19.9** | * | # | 1 | # |
| Ovary | * | # | 8 | 20.6** | * | # | 8 | 20.3** |
| Urinary Bladder | * | # | 5 | 12.1** | * | # | 0 | # |
| Kidney and Renal Pelvis | * | # | 4 | # | * | # | 2 | # |
| Brain and Other Nervous System | * | # | 4 | # | * | # | 3 | # |
| Non-Hodgkin Lymphoma | * | # | 11 | 28.6** | * | # | 4 | # |
| Myeloma | * | # | 3 | # | * | # | 2 | # |
| Leukemia | * | # | 1 | # | * | # | 2 | # |
Rates are per 100,000; Age-adjusted, 2000 U.S. Standard Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, October 2004
Table of Contents
Table 5-55: Morgan
Table 5-57: Noble
